Tag: buy

ROAD TOWN, British Virgin Islands, Aug. 14, 2025 (GLOBE NEWSWIRE) -- LYNO AI today announced that its Early Bird presale phase has achieved strong momentum, with over 265,000 tokens sold in a short span of time. Currently priced at $0.050 per token, this stage has attracted significant attention from the cryptocurrency community due to LYNO AI’s innovative offerings and favorable entry point.

Transaction in Own Shares   

NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, CANADA, JAPAN OR AUSTRALIA OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL

ROAD TOWN, British Virgin Islands, Aug. 14, 2025 (GLOBE NEWSWIRE) -- LYNO AI is hitting the headlines as its presale nears a major milestone, with a total of more than 269,879 tokens already sold during the Early Bird stage alone. The token price is now at 0.050 and will move to 0.055 in the near future presale phase. This boost underlines increasing investor confidence and the high demand of LYNO AI decentralized, AI-based cross-chain arbitrage protocol.

According to Towards Chemical and Materials, the global Oil & Gas market size was estimated at USD 6.10 Trillion in 2024 and is expected to surpass around USD 8.79 Trillion by 2034, growing at a compound annual growth rate (CAGR) of 3.72% over the forecast period from 2025 to 2034.

LEAWOOD, Kan., Aug. 13, 2025 (GLOBE NEWSWIRE) -- Euronet Worldwide, Inc. (“Euronet” or the “Company”) (Nasdaq: EEFT), a leading electronic payments provider, today announced the pricing of $850 million in aggregate principal amount of 0.625% Convertible Senior Notes due 2030 (the “notes”) in a private placement (the “offering”) to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”).

Los Angeles, CA, Aug. 13, 2025 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (“BioSig” or the “Company”), which recently merged with Streamex Exchange Corporation (“Streamex”) (NASDAQ: BSGM), today announced the pricing of its previously announced underwritten public offering of 3,852,149 shares of common stock at a public offering price of $3.90 per share. The offering is expected to close on or around August 15, 2025 subject to customary closing conditions. The gross proceeds from the offering, before deducting underwriter discounts and commissions and other estimated offering expenses are expected to be approximately $15,023,381.10. BioSig intends to use the net proceeds from the offering to purchase gold bullion in accordance with its investment policy, for working capital and for general corporate purposes.